The Clinical Impact of Flow Titration on Epoprostenol Delivery via High Flow Nasal Cannula for ICU Patients with Pulmonary Hypertension or Right Ventricular Dysfunction: A Retrospective Cohort Comparison Study
(1) Background: inhaled epoprostenol (iEPO) delivered via high-flow nasal cannula (HFNC) has been reported to be effective for pulmonary hypertension and right ventricular dysfunction. In vitro studies have identified HFNC gas flow as a key factor in trans-nasal aerosol delivery efficiency; however,...
Main Authors: | Jie Li, Payal K. Gurnani, Keith M. Roberts, James B. Fink, David Vines |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/2/464 |
Similar Items
-
Epoprostenol Delivered via High Flow Nasal Cannula for ICU Subjects with Severe Hypoxemia Comorbid with Pulmonary Hypertension or Right Heart Dysfunction
by: Jie Li, et al.
Published: (2019-06-01) -
The Ratio of Nasal Cannula Gas Flow to Patient Inspiratory Flow on Trans-nasal Pulmonary Aerosol Delivery for Adults: An in Vitro Study
by: Jie Li, et al.
Published: (2019-05-01) -
High-flow nasal cannula for body rewarming in hypothermia
by: Emanuele Gilardi, et al.
Published: (2020-03-01) -
In-vitro and in-vivo comparisons of high versus low concentrations of inhaled epoprostenol to adult intubated patients
by: Jie Li, et al.
Published: (2021-08-01) -
High Flow Nasal Cannulae in preterm infants
by: F. Ciuffini, et al.
Published: (2013-06-01)